Chronicling changes in the somatosensory neurons after peripheral nerve injury.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
20 10 2020
Historique:
pubmed: 7 10 2020
medline: 5 1 2021
entrez: 6 10 2020
Statut: ppublish

Résumé

Current drug discovery efforts focus on identifying lead compounds acting on a molecular target associated with an established pathological state. Concerted molecular changes that occur in specific cell types during disease progression have generally not been identified. Here, we used constellation pharmacology to investigate rat dorsal root ganglion neurons using two models of peripheral nerve injury: chronic constriction injury (CCI) and spinal nerve ligation (SNL). In these well-established models of neuropathic pain, we show that the onset of chronic pain is accompanied by a dramatic, previously unreported increase in the number of bradykinin-responsive neurons, with larger increases observed after SNL relative to CCI. To define the neurons with altered expression, we charted the temporal course of molecular changes following 1, 3, 6, and 14 d after SNL injury and demonstrated that specific molecular changes have different time courses during the progression to a pain state. In particular, ATP receptors up-regulated on day 1 postinjury, whereas the increase in bradykinin receptors was gradual after day 3 postinjury. We specifically tracked changes in two subsets of neurons: peptidergic and nonpeptidergic nociceptors. Significant increases occurred in ATP responses in nAChR-expressing isolectin B4+ nonpeptidergic neurons 1 d postinjury, whereas peptidergic neurons did not display any significant change. We propose that remodeling of ion channels and receptors occurs in a concerted and cell-specific manner, resulting in the appearance of bradykinin-responsive neuronal subclasses that are relevant to chronic pain.

Identifiants

pubmed: 33020310
pii: 1922618117
doi: 10.1073/pnas.1922618117
pmc: PMC7584894
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

26414-26421

Subventions

Organisme : NIGMS NIH HHS
ID : P01 GM048677
Pays : United States

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

J Neurosci. 2017 Apr 19;37(16):4391-4404
pubmed: 28330877
J Neurosci. 2002 Jun 15;22(12):5129-36
pubmed: 12077208
Nat Neurosci. 2018 Jun;21(6):869-880
pubmed: 29686262
Front Cell Neurosci. 2013 Nov 28;7:225
pubmed: 24348328
J Neurosci Methods. 1994 Jul;53(1):55-63
pubmed: 7990513
J Comp Neurol. 2007 May 10;502(2):325-36
pubmed: 17348016
Pain. 2000 Jun;86(3):265-71
pubmed: 10812256
Neuron. 2019 Aug 21;103(4):598-616.e7
pubmed: 31248728
Pain. 2000 Aug;87(2):149-58
pubmed: 10924808
Nat Neurosci. 2009 Nov;12(11):1364-6
pubmed: 19783992
Pain. 1992 Sep;50(3):355-63
pubmed: 1333581
Annu Rev Pharmacol Toxicol. 2015;55:573-89
pubmed: 25562646
Pain. 2011 Jul;152(7):1641-8
pubmed: 21474245
FEBS Lett. 2018 Apr;592(7):1045-1062
pubmed: 29030971
J Neurophysiol. 2016 Feb 1;115(2):1031-42
pubmed: 26581874
Sci Transl Med. 2015 May 13;7(287):287ra72
pubmed: 25972004
Neuron. 2016 Dec 7;92(5):1079-1092
pubmed: 27840000
Physiol Rev. 2012 Oct;92(4):1699-775
pubmed: 23073630
Sci Rep. 2017 Sep 20;7(1):11935
pubmed: 28931876
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8360-5
pubmed: 12060780
Pain. 2014 Oct;155(10):2097-107
pubmed: 25083927
Cell Rep. 2016 May 24;15(8):1771-81
pubmed: 27184839
J Neuroinflammation. 2018 Dec 20;15(1):349
pubmed: 30572902
Arch Int Pharmacodyn Ther. 1957 Sep 1;111(4):409-19
pubmed: 13471093
Nat Neurosci. 2015 Jan;18(1):145-53
pubmed: 25420068
Wellcome Open Res. 2018 Jun 25;3:78
pubmed: 30079380
Annu Rev Pharmacol Toxicol. 1980;20:441-62
pubmed: 7387124
Neurosci Lett. 2005 Mar 7;376(1):29-34
pubmed: 15694269
Pain. 1988 Apr;33(1):87-107
pubmed: 2837713

Auteurs

Shrinivasan Raghuraman (S)

School of Biological Sciences, University of Utah, Salt Lake City, UT 84112.

Jennifer Y Xie (JY)

Department of Pharmacology, University of Arizona Health Sciences, Tucson, AZ 85724.
Department of Basic Sciences, New York Institute of Technology College of Osteopathic Medicine at Arkansas State University, Jonesboro, AR 72467.

Mario J Giacobassi (MJ)

School of Biological Sciences, University of Utah, Salt Lake City, UT 84112.

Jortan O Tun (JO)

School of Biological Sciences, University of Utah, Salt Lake City, UT 84112.

Kevin Chase (K)

School of Biological Sciences, University of Utah, Salt Lake City, UT 84112.

Dong Lu (D)

Department of Pharmacology, University of Arizona Health Sciences, Tucson, AZ 85724.

Russell W Teichert (RW)

School of Biological Sciences, University of Utah, Salt Lake City, UT 84112.

Frank Porreca (F)

Department of Pharmacology, University of Arizona Health Sciences, Tucson, AZ 85724.

Baldomero M Olivera (BM)

School of Biological Sciences, University of Utah, Salt Lake City, UT 84112; olivera@biology.utah.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH